ReviewFrontiers in immunology2018
NKG2D Ligands-Critical Targets for Cancer Immune Escape and Therapy.
Dominik Schmiedel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
114 papers cite itlatest 60 shown
this papertrialcites it